The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Credit: Novo Nordisk. The approval was based on data from the randomized, double-blind, placebo-controlled FLOW trial. Semaglutide reduced the risk of kidney disease worsening, renal failure, and ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is ...

Apple’s new advent will feature specialized in-house components, including a modem chip, that can fit in a tighter package. The Cupertino, California-based company is reportedly endeavoring ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

THEY'RE ADVERTISED AS OZEMPIC OR WEGOVY. 12;40;15;00 THE GENERIC NAME IS SEMAGLUTIDE, THESE ARE IN A CLASS OF MEDICATIONS CALLED GLP1. DR. COHEN SAYS THIS IS A NATURALLY OCCURING HORMONE THAT CUES ...